These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 23009795)
101. Role of the angiogenic components, VEGFA, FGF2, OPN and RHOC, in urothelial cell carcinoma of the urinary bladder. Zaravinos A; Volanis D; Lambrou GI; Delakas D; Spandidos DA Oncol Rep; 2012 Oct; 28(4):1159-66. PubMed ID: 22895562 [TBL] [Abstract][Full Text] [Related]
102. Molecular subtype classification of urothelial carcinoma in Lynch syndrome. Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078 [TBL] [Abstract][Full Text] [Related]
103. Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract. Inoue S; Ide H; Fujita K; Mizushima T; Jiang G; Kawahara T; Yamaguchi S; Fushimi H; Nonomura N; Miyamoto H Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518027 [TBL] [Abstract][Full Text] [Related]
104. Case-control study of bladder cancer and exposure to arsenic in Argentina. Bates MN; Rey OA; Biggs ML; Hopenhayn C; Moore LE; Kalman D; Steinmaus C; Smith AH Am J Epidemiol; 2004 Feb; 159(4):381-9. PubMed ID: 14769642 [TBL] [Abstract][Full Text] [Related]
105. The association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China. Xu S; Zhang GM; Guan FJ; Dong DH; Luo L; Li B; Ma XC; Zhao J; Sun LJ World J Surg Oncol; 2015 Aug; 13():236. PubMed ID: 26246367 [TBL] [Abstract][Full Text] [Related]
106. Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study. Beebe-Dimmer JL; Iyer PT; Nriagu JO; Keele GR; Mehta S; Meliker JR; Lange EM; Schwartz AG; Zuhlke KA; Schottenfeld D; Cooney KA Environ Health; 2012 Jun; 11():43. PubMed ID: 22747749 [TBL] [Abstract][Full Text] [Related]
107. Polymorphism of VEGF-460C/T associated with the risk and clinical characteristics of lung cancer in Chinese population. Sun SF; Huang DB; Cao C; Deng ZC Med Oncol; 2013 Mar; 30(1):410. PubMed ID: 23288726 [TBL] [Abstract][Full Text] [Related]
108. Clinical significance of the VEGF level in urinary bladder carcinoma. Sankhwar M; Sankhwar SN; Abhishek A; Rajender S Cancer Biomark; 2015; 15(4):349-55. PubMed ID: 25792473 [TBL] [Abstract][Full Text] [Related]
109. Risk Factors Associated with Urothelial Bladder Cancer. Alouini S Int J Environ Res Public Health; 2024 Jul; 21(7):. PubMed ID: 39063530 [TBL] [Abstract][Full Text] [Related]
110. The joint effects of arsenic and risk diplotypes of insulin-like growth factor binding protein-3 in renal cell carcinoma. Huang CY; Huang YL; Pu YS; Shiue HS; Chen WJ; Chen SS; Lin YC; Su CT; Hsueh YM Chemosphere; 2016 Jul; 154():90-98. PubMed ID: 27038904 [TBL] [Abstract][Full Text] [Related]
111. The association between polymorphism of the BDNF gene and cigarette smoking in the Iranian population. Rajabi A; Khosravi P; Motevalian SA; Farjam M; Shojaei A J Gene Med; 2018 Oct; 20(10-11):e3052. PubMed ID: 30129980 [TBL] [Abstract][Full Text] [Related]
112. Urinary pH, cigarette smoking and bladder cancer risk. Alguacil J; Kogevinas M; Silverman DT; Malats N; Real FX; García-Closas M; Tardón A; Rivas M; Torà M; García-Closas R; Serra C; Carrato A; Pfeiffer RM; Fortuny J; Samanic C; Rothman N Carcinogenesis; 2011 Jun; 32(6):843-7. PubMed ID: 21402590 [TBL] [Abstract][Full Text] [Related]
113. Opium and Cigarette Smoking are Independently Associated with Bladder Cancer: The Findings of a Matched Case - Control Study. Abdolahinia Z; Pakmanesh H; Mirzaee M; Bazrafshan A; Shafiei Bafti M; Shahesmaeili A Asian Pac J Cancer Prev; 2021 Oct; 22(10):3385-3391. PubMed ID: 34711016 [TBL] [Abstract][Full Text] [Related]
114. Investigation of VEGF and IL-8 Gene Polymorphisms in Patients with Differentiated Thyroid Cancer. Kilic I; Guldiken S; Sipahi T; Palabiyik O; Akker M; Celik O; Soysal-Atile N; Tuncbilek N; Guven HM; Gundogdu AS; Sut N Clin Lab; 2016 Dec; 62(12):2319-2325. PubMed ID: 28164553 [TBL] [Abstract][Full Text] [Related]
115. The interaction between smoking and bladder cancer genetic variants on urothelial cancer risk by disease aggressiveness. Teleka S; Jochems SHJ; Jirström K; Stocks T Cancer Med; 2022 Aug; 11(15):2896-2905. PubMed ID: 35285182 [TBL] [Abstract][Full Text] [Related]
116. Polymorphisms of survivin -31 G/C gene are associated with risk of urothelial carcinoma in Serbian population. Bogdanovic L; Lazic M; Bogdanovic J; Soldatovic I; Nikolic N; Radunovic M; Radojevic-Skodric S; Milasin J; Basta-Jovanovic G J BUON; 2017; 22(1):270-277. PubMed ID: 28365965 [TBL] [Abstract][Full Text] [Related]
117. Urinary bladder cancer risk factors: a Lebanese case- control study. Kobeissi LH; Yassine IA; Jabbour ME; Moussa MA; Dhaini HR Asian Pac J Cancer Prev; 2013; 14(5):3205-11. PubMed ID: 23803105 [TBL] [Abstract][Full Text] [Related]
118. Cigarette smoking and subtypes of bladder cancer. Jiang X; Castelao JE; Yuan JM; Stern MC; Conti DV; Cortessis VK; Pike MC; Gago-Dominguez M Int J Cancer; 2012 Feb; 130(4):896-901. PubMed ID: 21412765 [TBL] [Abstract][Full Text] [Related]
119. Familial Cancer Clustering in Urothelial Cancer: A Population-Based Case-Control Study. Martin C; Leiser CL; O'Neil B; Gupta S; Lowrance WT; Kohlmann W; Greenberg S; Pathak P; Smith KR; Hanson HA J Natl Cancer Inst; 2018 May; 110(5):527-533. PubMed ID: 29228305 [TBL] [Abstract][Full Text] [Related]
120. CYP1B1 gene polymorphisms correlate with an increased risk of urinary bladder cancer in India. Sankhwar M; Sankhwar SN; Abhishek A; Gupta N; Rajender S Urol Oncol; 2016 Apr; 34(4):167.e1-8. PubMed ID: 26707614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]